Elizabeth Berry-Kravis focuses on Fragile X syndrome, FMR1, Ataxia, Psychiatry and Fragile X-associated tremor/ataxia syndrome. Her Fragile X syndrome study combines topics in areas such as Endocrinology, Internal medicine, Autism, Pediatrics and Neurological disorder. Her FMR1 research integrates issues from Metabotropic glutamate receptor 5, Neuroscience, Intellectual disability and Bioinformatics.
Her research investigates the connection between Ataxia and topics such as Genetics that intersect with issues in Congenital central hypoventilation syndrome and Sudden infant death syndrome. Her work deals with themes such as Genetic counseling and Fragile x, which intersect with Psychiatry. Her Fragile X-associated tremor/ataxia syndrome research is multidisciplinary, incorporating perspectives in Fragile X Tremor/Ataxia Syndrome, Trinucleotide repeat expansion, Intention tremor and Parkinsonism.
Elizabeth Berry-Kravis spends much of her time researching Fragile X syndrome, FMR1, Pediatrics, Internal medicine and Ataxia. To a larger extent, Elizabeth Berry-Kravis studies Psychiatry with the aim of understanding Fragile X syndrome. Her work carried out in the field of FMR1 brings together such families of science as Neuroscience and Audiology.
Her research investigates the link between Pediatrics and topics such as Congenital central hypoventilation syndrome that cross with problems in Autonomic nervous system. Her biological study spans a wide range of topics, including Gastroenterology, Endocrinology, Oncology and Cardiology. Her Ataxia study also includes fields such as
Her primary areas of investigation include Fragile X syndrome, Clinical psychology, FMR1, Autism spectrum disorder and Pediatrics. The Fragile X syndrome study combines topics in areas such as Irritability, Language development, Cognition, Autism and Comorbidity. Her study on FMR1 is covered under Genetics.
Her studies deal with areas such as Audiology, Intellectual disability, Item response theory, Social cognition and Catatonia as well as Autism spectrum disorder. The various areas that she examines in her Pediatrics study include Ataxia, Randomized controlled trial, Disease and Allele. Her research integrates issues of Rating scale, Clinical trial, Kinetic tremor and Cognitive decline in her study of Ataxia.
Her scientific interests lie mostly in Fragile X syndrome, Autism spectrum disorder, Intellectual disability, FMR1 and Clinical psychology. Elizabeth Berry-Kravis integrates many fields, such as Fragile X syndrome and Qualitative analysis, in her works. Elizabeth Berry-Kravis has researched Intellectual disability in several fields, including Decompensation, Down syndrome, Mental age and Pediatrics.
Elizabeth Berry-Kravis has included themes like Phenotype, Ataxia and Rating scale in her FMR1 study. Her work on Treatment development as part of general Clinical psychology study is frequently linked to Mailing list, bridging the gap between disciplines. Her studies in Autism integrate themes in fields like Language delay and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Fragile X Premutation Tremor/Ataxia Syndrome: Molecular, Clinical, and Neuroimaging Correlates
Sébastien Jacquemont;Randi J. Hagerman;Maureen Leehey;Jim Grigsby.
American Journal of Human Genetics (2003)
Penetrance of the Fragile X–Associated Tremor/Ataxia Syndrome in a Premutation Carrier Population
Sébastien Jacquemont;Randi J. Hagerman;Maureen A. Leehey;Deborah A. Hall.
JAMA (2004)
Advances in the treatment of fragile x Syndrome
Randi J Hagerman;Elizabeth Berry-Kravis;Walter E. Kaufmann;Michele Y. Ono.
Pediatrics (2009)
Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056
Sébastien Jacquemont;Aurore Curie;Vincent des Portes;Maria Giulia Torrioli.
Science Translational Medicine (2011)
Idiopathic congenital central hypoventilation syndrome: Analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2b
Debra E. Weese-Mayer;Elizabeth M. Berry-Kravis;Lili Zhou;Brion S. Maher.
American Journal of Medical Genetics Part A (2003)
An Official ATS Clinical Policy Statement: Congenital Central Hypoventilation Syndrome: Genetic Basis, Diagnosis, and Management
Debra E. Weese-Mayer;Elizabeth M. Berry-Kravis;Isabella Ceccherini;Thomas G. Keens.
American Journal of Respiratory and Critical Care Medicine (2010)
A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
Elizabeth M Berry-Kravis;David Hessl;Sarah Coffey;Crystal Hervey.
Journal of Medical Genetics (2009)
Fragile X Premutation Carriers: Characteristic MR Imaging Findings of Adult Male Patients with Progressive Cerebellar and Cognitive Dysfunction
James A. Brunberg;Sebastien Jacquemont;Randi J. Hagerman;Elizabeth M. Berry-Kravis.
American Journal of Neuroradiology (2002)
Fragile X syndrome
Randi J. Hagerman;Elizabeth Berry-Kravis;Heather Cody Hazlett;Donald B. Bailey.
Nature Reviews Disease Primers (2017)
Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status.
Denis A. Evans;David A. Bennett;Robert S. Wilson;Julia L. Bienias.
JAMA Neurology (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, Davis
University of California, Davis
University of California, Davis
University of California, Davis
University of Pittsburgh
Cincinnati Children's Hospital Medical Center
Emory University
Rush University Medical Center
University of Chicago
Rush University Medical Center
Swinburne University of Technology
Birkbeck, University of London
Czech Technical University in Prague
Technion – Israel Institute of Technology
Hong Kong University of Science and Technology
University of Kansas
Polytechnic University of Milan
York University
Centre d’Immunologie de Marseille-Luminy
Kyushu University
Bielefeld University
University of Oxford
The Ohio State University
Rutgers, The State University of New Jersey
Duke University
University of Southern Denmark